A validated method for urinary cotinine quantification used to classify active and environmental tobacco smoke exposure

Current Analytical Chemistry

Volumn 9, Issue 3, 2013, Pages 447-456

  Fustinoni, Silvia ^a   Campo, Laura ^a   Polledri, Elisa ^a   Mercadante, Rosa ^a   Erspamer, Laura ^b   Ranzi, Andrea ^b   Lauriola, Paolo ^b   Goldoni, Carlo Alberto ^c   Bertazzi, PierAlberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Regional Agency for Environmental Prevention of Emilia Romagna   (Italy)

^c Local Health Unit   (Italy)

Author keywords

Active tobacco smoke; Biomonitoring; Environmental tobacco smoke; LC MS MS; Urinary cotinine

Indexed keywords

SMOKE; TOBACCO;

ACTIVE TOBACCO SMOKE; BIOMONITORING; CLASSIFIEDS; CUT-OFF VALUE; ENVIRONMENTAL TOBACCO SMOKES; INTERNAL STANDARDS; LC-MS-MS; LC.MS/MS; TOBACCO SMOKE; URINARY COTININE;

MASS SPECTROMETRY;

EID: 84878631247     PISSN: 15734110     EISSN: None     Source Type: Journal    
DOI: 10.2174/1573411011309030014     Document Type: Article

References (37)

1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking, vol. 83. World Health Organization: Lyon, France, 2004.
2. Hukkanen, J.; Jacob III, P.; Benowitz, N.L. Metabolism and Disposition Kinetics of Nicotine. Pharmacol. Rev., 2005, 57, 79-115.
3. Zevin, S.; Jacob III, P.; Geppetti, P.; Benowitz, N.L. Clinical pharmacology of oral cotinine. Drug Alcohol Depend., 2000, 60, 13-18.
4. Matt, G.E.; Quintana, P.J.E.; Liles, S.; Hovell, M.F.; Zakarian, J.M.; Jacob III, P.; Benowitz, N.L. Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposure. Biomarkers, 2006, 11, 507-523.
5. Benowitz, N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev., 1996, 18, 188-204.
6. Haufroid, V.; Lison, D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int. Arch. Occup. Environ. Health, 1988, 71, 162-168.
7. Bramer, S.L.; Kallungal, B.A. Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers, 2003, 8, 187-203.
8. Fustinoni, S.; Consonni, D.; Campo, L.; Buratti, M.; Colombi, A.; Pesatori, A.C.; Bonzini, M.; Bertazzi, P.A.; Foà, V.; Garte, S.; Farmer, P.B.; Levy, L.S.; Pala, M.; Valerio, F.; Fontana, V.; Desideri, A.; Merlo, D.F. Monitoring low benzene exposure: comparative evaluation of urinary biomarkers, influence of cigarette smoking and genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 2237-2244.
9. Fustinoni, S.; Campo, L.; Satta, G.; Campagna, M.; Ibba, A.; Tocco, M.G.; Atzeri, S.; Avataneo, G.; Flore, C.; Meloni, M.; Bertazzi, P.A.; Cocco, P. Environmental and lifestyle factors affect benzene uptake biomonitoring of residents near a petrochemical plant. Environ. Int., 2012, 39, 2-7.
10. Protano, C.; Andreoli, R.; Manini, P.; Guidotti, M.; Vitali, M. A tobacco-related carcinogen: assessing the impact of smoking behaviours of cohabitants on benzene exposure in children. Tob. Control,. 2012, 21, 325-329.
11. Florescu, A.; Ferrence, R.; Einarson, T.; Selby, P.; Soldin, O.; Koren, G. Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther. Drug Monit., 2009, 31, 14-30.
12. Jarvis, M.J.; Tunstall-Pedoe, H.; Feyerabend, C.; Vesey, C.; Saloojee, Y. Comparison of tests used to distinguish smokers from nonsmokers. Am. J. Public Health, 1987, 77, 1435-1438.
13. Kuo, W.; Yang, J.-S.; Chiu, M.-C. Determination of urinary and salivary cotinine using gas and liquid chromatography and enzymelinked immunosorbent assay. J. Chromatogr. B, 2002, 768, 297-303.
14. Binnie, V.; McHugh, S.; Macpherson, L.; Borland, B.; Moir, K.; Mal, K. The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine. Oral Dis., 2004, 10, 287-293.
15. Man, C.N.; Gam, L.-H.; Ismail, S.; Lajis, R.; Awang, R. Simple, rapid and sensitive assay method for simultaneous quantification of urinary cotinine using gas chromatography-mass spectrometry. J. Chromatogr. B., 2006, 844, 322-327.
16. Lequang Thuan, N.T.; Migueres, M.L.; Roche, D.; Roussel, G.; Mahuzier, G.; Chretien, J.; Ekindjian, O.G. Elimination of caffeine interference in HPLC determination of urinary nicotine and cotinine. Clin. Chem., 1989, 35, 1456-1459.
17. Moyer, T.P.; Charlson, J.R.; Enger, R.J.; Dale, L.C.; Ebbert, J.O.; Schroeder, R.D.; Hurt, R.D. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin. Chem., 2002, 48, 1460-1471.
18. Song, L.; Davis, W.; Abrams, S.M.; Hemiup, J.; Kazim, A.L.; Cummings, K.M.; Mahoney, M.C. Sensitive and rapid method for the determination of urinary cotinine in non-smokers: an application for studies assessing exposures to second hand smoke (SHS). Anal. Chim. Acta, 2005, 545, 200-208.
19. Jacob III, P.; Yu, L.; Duan, M.; Ramos, L.; Yturralde, O.; Benowitz, N.L. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and nonsmokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J. Chromatogr. B, 2011, 879, 267-276.
20. Meger, M.; Meger-Kossien, I.; Schuler-Metz, A.; Janket, D.; Scherer, G. Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatographytandem mass spectrometry. J. Chromatogr. B, 2002, 778, 251-261.
21. Hoofnagle, A.N.; Laha, T.J.; Rainey, P.M.; Sadrzadeh, S.M.H. Specific detection of anabasine, nicotine, and nicotine metabolites in urine by liquid chromatography-tandem mass spectrometry. Am. J. Clin. Pathol., 2006, 126, 880-887.
22. Fan, Z.; Xie, F.; Xia, Q.; Wang, S.; Ding, L.; Liu, H. Simultaneous determination of nicotine and its metabolites in human urine by LC-MS-MS. Chromatographia, 2008, 68, 623-627.
23. Food and Drug Administration. Guidance for Industry-Bioanalytical Method. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM070107.pdf (accessed February 17, 2011).
24. Matuszewski, B.K. Standard lines slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J. Chromatogr. B, 2006, 830, 293-300.
25. Aquilina, N.J.; Delgado-Saborit, J.M.; Meddings, C.; Baker, S.; Harrison, R.M.; Jacob, P. 3rd; Wilson, M.; Yu L, Duan, M.; Benowitz, N.L. Environmental and biological monitoring of exposures to PAHs and ETS in the general population. Environ. Int., 2010, 36, 763-771.
26. Conrad, A.; Schulz, C.; Seiwert, M.; Becker, K.; Ullrich, D.; Kolossa-Gehring, M. German environmental survey IV: children's exposure to environmental tobacco smoke. Toxicol. Lett., 2010, 192, 79-83.
27. Miller, E.I.; Norris, H.-R.K.; Rollins, D.E.; Tiffany, S.T.; Wilkins, D.G. A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Chromatogr. A, 2010, 878, 725-737.
28. Achutan, C.; West, C.; Mueller, C.; Bernert, J.T.; Bernard, B. Environmental tobacco smoke exposure among casino dealers. J. Occup. Environ. Med., 2011, 53, 346-351.
29. Man, C.N.; Fathelrahman, A.I.; Harn, G.L.; Lajis, R.; Samin, A.S.; Omar, M.; Awang, R.; Bayanuddin, N.A. Correlation between urinary nicotine, cotinine and self-reported smoking status among educated young adults. Environ. Toxicol. Pharmacol., 2009, 28, 92-6.
30. Italian Legislation n.3, Art. 51, 16 January 2003 (Tutela della salute dei non fumatori) Gazzetta Ufficiale n.15, 20 January 2003, Supplemento ordinario n°5, enforced from 10 January 2005. Available on line at: http://www.governo.it/GovernoInforma/Dossier/ tabagismo/legge_3_2003.pdf (accessed April 21, 2011).
31. Goniewicz, M.L.; Eisner, M.D.; Lazcano-Ponce, E.; Zielinska-Danch, W.; Koszowski, B.; Sobczak, A.; Havel, C.; Jacob, P., Benowitz, N.L. Comparison of urine cotinine and the tobaccospecific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob. Res., 2011, 13, 202-208.
32. Benowitz, N.L. Biomarkers of environmental smoke exposure. Environ. Health Perspect., 1999, 107 (Suppl. 2), 349-355.
33. Bavazzano, P.; Perico, A.; Boddi, V.; Lorini, C.; Cavaciocchi, D.; Lanciotti, E. Most sensitive urinary cotinine cut-off level for environmental tobacco smoke exposure assessment: a pilot study. Ann. Ig., 2007, 19:225-33.
34. Simoni, M.; Baldacci, S.; Puntoni, R.; Pistelli, F.; Farchi, S.; Lo Presti, E.; Pistelli, R.; Corbo, G.; Agabiti, N.; Basso, S.; Matteelli, G.; Di Pede, F.; Carrozzi, L.; Forastiere, F.; Viegi, G. Plasma, salivary and urinary cotinine in non-smoker Italian women exposed and unexposed to environmental tobacco smoking (SEASD study). Clin. Chem. Lab. Med., 2006, 44, 632-8.
35. Sasaki, S.; Braimoh, T.S.; Yila, T.A.; Yoshioka, E.; Kishi, R. Selfreported tobacco smoke exposure and plasma cotinine levels during pregnancy-A validation study in Northern Japan. Sci. Total Environ., 2011, 412-413, 114-8.
36. Benowitz, N.L.; Kuyt, F.; Jacob, P. 3rd; Jones, R.T.; Osman, A.L. Cotinine disposition and effects. Clin. Pharmacol. Ther., 1983, 34, 604-11
37. Jatlow, P.; McKee, S.; O'Malley, S.S. Correction of urine cotinine concentrations for creatinine excretion: is it useful? Clin. Chem., 2003, 49, 1932-4.